Moreover, scRNA-seq of tumor samples showed that a higher proportion of CD8+ cells with increased expressions of memory, activation, and survival-associated genes compared to exhaustion genotype of CD8+ T cells correlated with a positive outcome in patients with metastatic melanoma receiving ICB treatment. This evidence concerns the gene CD8A and metastatic melanoma.